Back to results
US 2016/0251340 A1Published application
Hydantoin derivatives useful as kv3 inhibitors
AssigneeAutifony Therapeutics Limited
InventorsGiuseppe ALVARO, Paolo DAMBRUOSO, Simona TOMMASI, Anne DECOR, Charles LARGE, Agostino MARASCO
Life of this patent
Estimating the term…
Abstract
The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
Claims1
A compound selected from:
- spiro[1-benzofuran-3,1′-cyclopropan]-4-ol
- 7-methylspiro[2H-benzofuran-3,1′-cyclopropane]-4-ol
- and
- 3,3,7-trimethyl-2,3-dihydro-1-benzofuran-4-ol
- or a salt thereof;
- or
- a compound selected from:
- wherein:
- X is C or N;
- Y is C or N;
- and
- the group W is selected from:
- or a salt thereof.
10 more elements
Dependencies are inferred from the claim text.